Researchers utilized DNA and RNA platforms to compare virus-like particle vaccines with premembrane and ZIKV envelope expressed either in the wild-type form or with fusion loop mutations, which limit antibody-dependent enhancement of infection.
[Nature Microbiology]

Cancer Stem Cell News
Cell Therapy News
Dermal Cell News
Endothelial Cell News
ESC & iPSC News
Extracellular Matrix News
Hematopoiesis News
Hepatic Cell News
Human Immunology News
Immune Regulation News
Intestinal Cell News
Mammary Cell News
Mesenchymal Cell News
Muscle Cell News
Neural Cell News
Organoid News
Pancreatic Cell News
Prostate Cell News
Pulmonary Cell News